Fig. 3.

Pooled adjusted estimates on the association between prior ICI exposure with risks of a mortality and b severity. ICI, immune checkpoint inhibitor. ^aOverlapping populations were observed between Pinato et al. [27] with Garassino et al. [34] and Lee et al. [26], of which Pinato et al. [27]. ^bEffect size was derived by combining multiple groups into a single pair-wise comparison. ^cOverlapping populations were observed between Luo et al. [30] and Robilotti et al. [31], of which Robilotti [31] et al. was prioritized due to larger sample size